Protagonist Therapeutics (PTGX) Earnings
|
Expand Research on PTGX
| Next EPS Date | 5/1/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +10.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +25.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/20 |  |
Q120 | -$0.72 | -$0.69 | -$0.03 | N/A | $1.48M | N/A |  | | Details |
| 3/12/19 | |
Q418 | -$0.57 | -$0.47 | -$0.10 | $2.35M | $4.83M | N/A | | | Details |
8/3/23  |
Q223 | -$0.68 | -$0.65 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 5/1/24 | Q124 | N/A | $1.19 | N/A | N/A | $120M | N/A | N/A | N/A | ||
| 3/10/21 |
|
Q420 | N/A | -$0.48 | N/A | N/A | $3.12M | N/A | N/A | N/A | |
| 3/8/23 | Q422 | N/A | -$0.64 | N/A | N/A | $6M | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.70 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/27/24 | Q423 | N/A | -$0.14 | N/A | $60M | $40M | N/A | N/A | N/A |
